Spanish Red Biotech Pipeline

MSD

MK1454/Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Intratumoral MK-1454 plus Pembrolizumab First Line Metastatic or Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma
Phase: 2Phase II in Spain, 1Phase I